Bruker's board members were re-elected this week, while Andre Marion joined Microchip Biotechnologies board, DxS announced promotions, Jai Nagarkatti is set to take over as chairman of Sigma-Aldrich, and more.
Bruker has re-elected Tony Keller, Richard Kniss, Joerg Laukien, and William Linton to continue serving on its board of directors. The four were re-elected as Class III directors at the company's annual stockholder meeting, and they will serve three-year terms.
Andre Marion has joined Microchip Biotechnologies' board of directors. Marion was a CEO and co-founder of Applied Biosystems. Marion originally was VP of Engineering at ABI and he took on the post of CEO in 1986. He retired as president of the Applied Biosystems division of Perkin-Elmer in 1993.
Barbara Schaal, a professor at Washington University in St. Louis and VP of the National Academy of Sciences, will join the President's Council of Advisors on Science and Technology. Schaal, a biologist focused on quantitative genetics and molecular biology-based studies of evolution in plants, will serve as a science policy adviser for the White House.
DxS has appointed COO Jeff Devlin to serve on its board and has promoted Peter Collins to be senior VP of business development. Before starting at DxS, Devlin was executive VP of Shire Pharmaceuticals and a partner in Ernst and Young's life science division. Collins has held senior executive roles at Vysis Europe, Quantase, Gentronix, Biogenix, and Pronostics.
David Harvey has retired from his position as chairman at Sigma-Aldrich, but he will continue on as a company director. Jai Nagarkatti, who is currently president, CEO, and director of the company, will take on the additional role of chairman. The company's board also has promoted Barrett Toan to serve as presiding director, and it re-elected directors W. Lee McCollum; Rebecca Bergman; Avi Nash; Steven Paul; J. Pedro Reinhard; Timothy Sear; and Dean Spatz as directors.
DNA Diagnostics Center has named Marco Scarpetta to be laboratory director. Scarpetta formerly was lab director at Orchid Cellmark, and he has over 15 years of experience in forensic and paternity DNA testing.
Integrated Genomics has appointed Jose Laplaza as director of strain engineering and lab operations. Laplaza formerly was bioscience team leader and scientist at Cargill BioTDC, and he worked at the US Department of Agriculture's Forest Service.
John Bell, who is president of the UK's Academy of Medical Sciences, is the 2009 winner of the Henry G. Friesen International Prize in Health Research, which was established by the Friends of Canadian Institutes of Health Research with the Canadian Academy of Health Sciences and CBC Radio to recognize medical innovation. Bell, who is founder of the Wellcome Trust Centre for Human Genetics, has conducted research focusing on finding the genetic susceptibilities to auto-immune diseases.
El Camino Hospital in Silicon Valley has appointed Paul Billings to serve as acting director and CSO of the hospital's Genomic Medicine Institute, which will provide genomic medicine services for doctors and patients in a community hospital.
Billings is co-founder of GeneSage, co-founder of CBR Systems, advisor for CELLective DX, and he was senior VP for corporate development and senior geneticist at Laboratory Corporation of American Holdings.
GenVault has hired Shane Lyons to be VP of Sales and Marketing. Lyons previously was VP of sales, Americas, for the protein and small molecule division of Life Technologies (formerly Applied Biosystems), where he managed the sales organization and growth of the mass spectrometry business, and held other positions. Lyons also has worked at PerSeptive Biosystems, Abbott Labs, Unipath/Unilever, and Coulter Electronics.
Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People in the News, a weekly roundup of industry comings and goings.